Product Information

PIMOZIDE 1 MG TABLET is a generic product labeled by Endo USA Inc., priced at $1.2398 per EA under NDC 49884034701. Its NADAC has been published 275 times since May 18, 2016.

FDA first approved this application on Sep 28, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

PIMOZIDE 1 MG TABLET

Pimozide
$1.2398per EA

Strength

1 mg/1

Manufacturer

Endo USA Inc.

NDC

49884034701

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

PIMOZIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA204521

FDA Approved

9/28/2015

TE Code

AB

On Market Since

9/28/2015

Pharmacological Classes

Price Statistics

The NADAC for PIMOZIDE 1 MG TABLET has been published 275 times since May 18, 2016, and over the history we have for it it has declined 16.1%. The table below summarizes its recorded NADAC range and movement.

Current price$1.2398 per EA
All-time high$1.4781 (Jun 15, 2016)
All-time low$1.1466 (Jul 17, 2024)
52-week high$1.2631
52-week low$1.2295
Median price$1.3169
Average price$1.3076
Largest weekly change-8.4% (Apr 17, 2024)
Weeks tracked275
Tracking sinceMay 18, 2016

Price History

1W

0.0%

1M

+0.4%

3M

+0.4%

6M

-0.3%

1Y

-3.0%

3Y

-7.4%

5Y

-7.4%

All

-16.1%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Pimozide market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of PIMOZIDE 1 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for PIMOZIDE 1 MG TABLET, manufactured by Endo USA Inc., is $1.2398 per EA (NDC 49884034701), effective Nov 11, 2026.

How has the price of PIMOZIDE 1 MG TABLET changed over time?

Over the history we have for it, the NADAC for PIMOZIDE 1 MG TABLET has declined 16.1%. It has been tracked across 275 weekly CMS publications since May 18, 2016.

What are the highest and lowest recorded NADAC prices for PIMOZIDE 1 MG TABLET?

Since May 18, 2016, the NADAC for PIMOZIDE 1 MG TABLET has ranged from a low of $1.1466 (Jul 17, 2024) to a high of $1.4781 (Jun 15, 2016), with a median of $1.3169 per EA.

Are there cheaper alternatives to PIMOZIDE 1 MG TABLET?

No other NADAC-published product currently shares the active ingredient and strength of PIMOZIDE 1 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures PIMOZIDE 1 MG TABLET?

PIMOZIDE 1 MG TABLET (NDC 49884034701) is labeled by Endo USA Inc., and CMS classifies it as a generic product.